These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 6322365)
41. Naltrexone-reversible effects of flunitrazepam on locomotor activity and passive avoidance behaviour in mice. Castellano C; Filibeck U; Pavone F Eur J Pharmacol; 1984 Sep; 104(1-2):111-6. PubMed ID: 6499910 [TBL] [Abstract][Full Text] [Related]
42. [Effect of echinopsin and adepren on motor activity in rats]. Stefanova D; Daleva L Eksp Med Morfol; 1978; 17(4):202-7. PubMed ID: 729528 [TBL] [Abstract][Full Text] [Related]
44. The effect of bovine fibrinopeptides on the central action of chlorpromazine and amphetamine in rats. Buczko W Acta Neurobiol Exp (Wars); 1976; 36(4):447-54. PubMed ID: 983820 [TBL] [Abstract][Full Text] [Related]
45. Supersensitivity of brain opiate receptor subtypes after chronic naltrexone treatment. Tempel A; Zukin RS; Gardner EL Life Sci; 1982 Sep 20-27; 31(12-13):1401-4. PubMed ID: 6292636 [No Abstract] [Full Text] [Related]
46. Naltrexone blocks amphetamine-induced hyperactivity, but not disruption of social and agonistic behavior in mice and squirrel monkeys. Winslow JT; Miczek KA Psychopharmacology (Berl); 1988; 96(4):493-9. PubMed ID: 3149772 [TBL] [Abstract][Full Text] [Related]
47. Enhanced analgesic effects of stress following chronic administration of naltrexone in rats. Amir S; Amit Z Eur J Pharmacol; 1979 Oct; 59(1-2):137-40. PubMed ID: 510393 [TBL] [Abstract][Full Text] [Related]
49. Naltrexone modulates body and brain development in rats: a role for endogenous opioid systems in growth. Zagon IS; McLaughlin PJ Life Sci; 1984 Nov; 35(20):2057-64. PubMed ID: 6092812 [TBL] [Abstract][Full Text] [Related]
51. Opiate receptors may mediate the suppressive but not the excitatory action of ACTH on motor activity in rats. Amir S; Galina ZH; Blair R; Brown ZW; Amit Z Eur J Pharmacol; 1980 Sep; 66(4):307-13. PubMed ID: 6252015 [TBL] [Abstract][Full Text] [Related]
52. Potentiation by naltrexone of d-amphetamine-induced behavioral suppression and its reversal by clonidine. Fossom LH; Sparber SB Life Sci; 1982 Dec; 31(25):2827-35. PubMed ID: 7162354 [No Abstract] [Full Text] [Related]
53. Effects of yohimbine and naltrexone in counteraction of the morphine Straub tail and the amphetamine-potentiated morphine Straub tail in mice. Blumberg H; Slovak DM Life Sci; 1982 Jun; 30(24):2115-21. PubMed ID: 7109840 [No Abstract] [Full Text] [Related]
54. Chronic naltrexone treatment increases the heroin-produced facilitation of self-stimulation. Schenk S; Nawiesniak E Pharmacol Biochem Behav; 1985 Feb; 22(2):175-7. PubMed ID: 2984700 [TBL] [Abstract][Full Text] [Related]
55. Chronic blockade of opiate receptors: influence on reproduction and body weight in female rats. Pfeiffer DG; Nikolarakis KE; Pfeiffer A Neuropeptides; 1984 Dec; 5(1-3):279-82. PubMed ID: 6099513 [No Abstract] [Full Text] [Related]
56. Effects of naloxone and diprenorphine on amphetamine-stimulated behavior in guinea pigs and rats. Andrews JS; Holtzman SG Neuropharmacology; 1987 Aug; 26(8):1115-20. PubMed ID: 3658118 [TBL] [Abstract][Full Text] [Related]
57. Effects of naloxone infusion upon spontaneous and amphetamine-induced activity. Jones DN; Holtzman SG Eur J Pharmacol; 1992 Oct; 221(1):161-5. PubMed ID: 1333971 [TBL] [Abstract][Full Text] [Related]
59. [The effect of unithiol (2-mercapto-propane sulfonate sodium) on the motor activity stimulated by amphetamine, on evipan anesthesia and on the activity of dopamine-beta-hydroxylase]. Stoichev Ts; Koleva M; Kirova A Eksp Med Morfol; 1974; 13(2):118-23. PubMed ID: 4374349 [No Abstract] [Full Text] [Related]
60. Interactions between naltrexone and non-opiate drugs evaluated by schedule-controlled behavior. Harris RA; Snell D Neuropharmacology; 1980 Nov; 19(11):1087-93. PubMed ID: 7442939 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]